Neo Pharma Private Limited - Company Profile

It is a real estate and construction private limited company based in Mumbai, Maharashtra, India, established in 1950.
1950 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Neo Pharma Private Limited

Neo Pharma Private Limited, a active private limited company, was established on 09 March 1950 in Mumbai, Maharashtra, India. Engaging in real estate builders & developers within the construction sector, it holds CIN: U24239MH1950PTC008016. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.09 Cr and a paid-up capital of ₹6.02 M.

Formerly known as Neo Pharma Limited, Neo-Pharma Private Limited. It upholds a compliant status. Employing 43 professional, Its leadership includes Jayant Chaganlal Oswal (Director), Nikunj Pravinchandra Pandya (Additional Director). Past directors included Rajesh Bhagchand Golechha, Bajrang Lal Bararia, Imtiaz Ismail Kanga. It holds ₹4,947.31 Cr open charges and ₹1,458.00 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kasturi Buildingj Tata Road, Mumbai, Maharashtra, 400020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1950PTC008016

  • Registration Number

    008016

  • Incorporation Date

    09 March 1950

  • Authorized Capital

    ₹1.09 Cr

  • Paid-Up Capital

    ₹6.02 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.09 Cr
  • Paid Up Capital ₹ 6.02 M
  • Company Age 75 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4,947.31 Cr
  • Satisfied Charges ₹ 1,458.00 Cr
  • Revenue Growth **** -35.62%
  • Profit Growth **** -53.30%
  • Ebitda **** -51.82%
  • Net Worth 3.86%
  • Total Assets **** 7.40%
Company report

Neo Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Neo Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayant Chaganlal Oswal Director 28 Mar 2015 Current
Nikunj Pravinchandra Pandya Additional Director 18 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Mar 2015 Past
Pramod Abcsdd Additional Director 31 Dec 2021 Past
Pramod Abcsdd Director 28 Mar 2015 Past
Pramod Abcsdd Director 15 Feb 2011 Past
Pramod Abcsdd Director 30 Nov 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neo Pharma.

Neo Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.62% decrease. The company also saw a substantial fall in profitability, with a 53.3% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.

Neo Pharma revenue growth over time
Neo Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -35.62%
*******
*******
*******
*******
Revenue from Operations
*******
 -59.11%
*******
*******
*******
*******
Total Assets
*******
 7.40%
*******
*******
*******
*******
Profit or Loss
*******
 -53.30%
*******
*******
*******
*******
Net Worth
*******
 3.86%
*******
*******
*******
*******
EBITDA
*******
 -51.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neo Pharma?

In 2023, Neo Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹49,473,088,740.00

Satisfied Charges

₹14,580,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4572.31 Cr
  • Others : 375.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Sep 2024 Others ₹55.00 Cr Open
30 Apr 2021 Hdfc Bank Limited ₹4,572.31 Cr Open
23 Oct 2019 Others ₹95.00 Cr Open
14 Feb 2018 Others ₹225.00 Cr Open
22 Apr 2022 Others ₹100.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neo Pharma?

Neo Pharma has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neo Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neo Pharma
Recent Activity within the Organization
  • Charges

    A charge registered on 31 Mar 2021 via Charge ID 100442351 with Others was fully satisfied on 15 Oct 2025. was recorded as a recent event.

  • Director Appointment

    Nikunj Pravinchandra Pandya was appointed as a Additional Director was appointed as a Additional Director on 18 Apr 2025 & has been associated with this company since 9 months 24 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 95.00 Cr registered on 23 Oct 2019 with Charge ID 100302194 was modified on 07 Jan 2025. was documented.

  • Charges

    A charge registered on 11 Nov 2020 via Charge ID 100392779 with Others was fully satisfied on 11 Nov 2024. was recorded as a recent event.

  • Charges

    A charge registered on 11 Nov 2020 via Charge ID 100392780 with Others was fully satisfied on 11 Nov 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 55.00 Cr with Charge ID 101003869 was registered on 30 Sep 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neo Pharma Private Limited?

The CIN of Neo Pharma Private Limited is U24239MH1950PTC008016.

Where is Neo Pharma Private Limited headquartered?

Neo Pharma Private Limited is headquartered at Kasturi Buildingj Tata Road, Mumbai, Maharashtra, 400020.

When was Neo Pharma Private Limited incorporated?

Neo Pharma Private Limited was incorporated on 09 March 1950.

Who are the current directors of Neo Pharma Private Limited?

The current directors of Neo Pharma Private Limited are

What is the primary industry of Neo Pharma Private Limited?

The primary industry of Neo Pharma Private Limited is Construction.

Is Neo Pharma Private Limited a listed company?

Neo Pharma Private Limited is unlisted.

What is the capital structure of Neo Pharma Private Limited?

The authorized capital of Neo Pharma Private Limited is ₹1.09 Cr, and the paid-up capital is ₹6.02 M.

What is the compliance status of Neo Pharma Private Limited?

The compliance status of Neo Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available